ClinicalTrials.Veeva

Menu

Validation of Drug Assays in Various Biological Matrices

H

Helen Reynolds

Status

Enrolling

Conditions

Infection

Treatments

Other: antivirals, antimicrobials, oral contraceptive, erectile dysfunction agents

Study type

Observational

Funder types

Other

Identifiers

NCT02283112
RLUH 4520

Details and patient eligibility

About

This study aims to ensure that assays that measure drug concentrations are accurate and precise in different matrices when quantified using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS). The study involves collecting samples of various bodily fluids to quantify antimicrobials, antivirals, oral contraceptives and erectile dysfunction agents. Samples will also be obtained from individuals not receiving these medications for quality control purposes.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • > 18 years of age

Exclusion criteria

  • Unable to give informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Helen Reynolds

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems